Brussels, 31 Jan 2003
Tissue engineering is a new and rapidly developing technology that intends to produce viable substitutes that restore, maintain or improve the function of human tissues or organs.
It differs from standard therapies by the fact that the engineered products become integrated within the patient, affording a potentially permanent and specific cure of the disease, injury or impairment. It is an inter disciplinary field that applies the principles of biology and engineering.
It is important to establish a clear regulatory framework for this area.
The attached consultation document invited contributions on the need and contents of such a framework.
The consultation was open until September 30, 2002.